nepafenac has been researched along with Myopia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chronopoulou, KG; Kontadakis, GA; Kymionis, GD; Tabibian, D; Tsopouridou, R | 1 |
| Boxer Wachler, BS; Jalali, S; Yuen, LH | 1 |
| McDonald, M; Trattler, W | 1 |
| Toyos, R | 1 |
| Holland, E; Lane, S; Lindstrom, R; Raizman, M; Reilly, C | 1 |
2 trial(s) available for nepafenac and Myopia
| Article | Year |
|---|---|
Nepafenac Ophthalmic Suspension 0.3% for the Management of Ocular Pain After Photorefractive Keratectomy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Astigmatism; Benzeneacetamides; Eye Pain; Female; Humans; Lasers, Excimer; Male; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Photorefractive Keratectomy; Prospective Studies; Suspensions; Visual Acuity; Wound Healing; Young Adult | 2018 |
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Opacity; Double-Blind Method; Female; Humans; Hyperopia; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Male; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Prospective Studies; Visual Acuity; Wound Healing | 2007 |
3 other study(ies) available for nepafenac and Myopia
| Article | Year |
|---|---|
Effect of nepafenac sodium 0.1% on delayed corneal epithelial healing and haze after photorefractive keratectomy: retrospective comparative study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Corneal Opacity; Epithelium, Corneal; Female; Humans; Lasers, Excimer; Male; Myopia; Ophthalmic Solutions; Phenylacetates; Photorefractive Keratectomy; Prodrugs; Retrospective Studies; Visual Acuity; Wound Healing | 2008 |
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Opacity; Double-Blind Method; Humans; Hyperopia; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Multicenter Studies as Topic; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Randomized Controlled Trials as Topic; Visual Acuity; Wound Healing | 2008 |
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Opacity; Double-Blind Method; Humans; Hyperopia; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Randomized Controlled Trials as Topic; Visual Acuity; Wound Healing | 2008 |